Timothy Janetos, MD, explained when to refer uveitis to a specialist and why access to uveitis care remains limited.

Taken together, these three responses point to gaps beyond the next therapy: in how academic medicine is valued, in what ...

A higher risk of central serous chorioretinopathy and serous pigment epithelial detachment are associated with varicose veins.

Ryzumvi (phentolamine ophthalmic solution 0.75%) is approved for the treatment of presbyopia in adults. It is also approved for pharmacologically induced mydriasis produced by adrenergic agonists or ...

The FDA has approved Enspryng (satralizumab, Genentech) for thyroid eye disease (TED), making the drug the first subcutaneous ...

At AAO 2026, Adam, MD, shares Yamane technique pearls, from docking the trailing haptic to preventing tilt and haptic ...

Eclipse Life Sciences reports that its biodegradable 6-month fluocinolone acetonide implant met its primary safety end point ...

Jacque Duncan, MD, reviews phase 3 DRAGON data on oral tinlarebant for Stargardt disease and its mechanism-related visual ...

Restoring sight after whole human eye transplant remains a long-term goal, and the optic nerve is the limiting factor, ...

Kenneth C. Fan, MD, MBA, shared 4-year REMAIN data showing durable vision gains with MCO-010 in retinitis pigmentosa.

Alvotech and Advanz Pharma have submitted a European regulatory application for AVT29, a proposed biosimilar to high-dose ...

Noah Banoub, a third year medical student, describes his journey into medicine and his choice of specialty. He recounted how MacTel type 2 went from being a diagnosis of exclusion without a therapy to ...